insulin, Lupin Limited and Eli Lilly

Lupin up 2%, hits new high on buying Eli Lilly's diabetes drug Huminsulin
The stock of the pharmaceutical company, Lupin is quoting higher for the sixth straight trading day; it has rallied 10 per cent during the period
Lupin Shares Rise 3% To Record High Level After Acquiring Huminsulin From Ely Lily
Indian pharma giant Lupin's shares surged more than 2 per cent to touch the all time high level after the company declared that it had added Huminsulin in India to its diabetes portfolio by purchasing it from Eli Lilly and Co.
Lupin acquires Huminsulin from Lilly to Enhance Diabetes Portfolio
Global pharma major Lupin Limited announced today the acquisition of Huminsulin® in India from Eli Lilly and Company to further enhance its diabetes portfolio.
Shares of Lupin Ltd reach all-time high price on acquiring Huminsulin from Eli Lilly
Lupin Ltd. acquires Huminsulin range from Eli Lilly, strengthening its position in the Indian diabetes market.
Lupin To Acquire Huminsulin In India From Eli Lily To Augment Diabetes Portfolio
Lupin strengthens its diabetes portfolio with the acquisition of Huminsulin products from Eli Lilly, including Insulin Human formulations, widely used for managing type 1 and type 2 diabetes mellitus
Diabetes treatment: Lupin buys Huminsulin from Eli Lilly
Mumbai: Global pharma major Lupin Limited has announced the acquisition of Huminsulin in India from Eli Lilly and Company to further enhance its diabetes portfolio. Lupin has been marketing
Lupin acquires Huminsulin from Lilly to strengthen diabetes portfolio
The Huminsulin range is vital for managing both type 1 and type 2 diabetes, helping control blood sugar levels in adults and children
Lupin acquires Huminsulin in India to strengthen diabetes care portfolio
Global pharma company Lupin announced the acquisition of Huminsulin in India from Eli Lilly and Company (Lilly), aiming to expand its diabetes care portfolio. Lupin has been marketing the Huminsulin range under existing distribution and promotion agreements with Lilly in India.
Hosted on MSN2d
Lupin Share Price: BSE 100 pharma stock hits 52-week high on last day of 2024! Reason: New acquisition
Shares of the pharma stock rose around 2.5 per cent on Tuesday. Lupin share price has a 52-week range of Rs 2,369.90 and Rs 1 ...
ndtvprofit2d
Lupin Shares Hit Life High Following Huminsulin Acquisition
Nilesh Gupta, Managing Director of Lupin, emphasised that this acquisition aligns with the company’s commitment to expanding ...
Drug Store News6d
Lupin receives FDA nod for generic Descovy
The drug is indicated for the treatment of HIV-1 infection and for pre-exposure prophylaxis to reduce the risk of HIV-1 ...
moneycontrol.com2d
Stocks to Watch Today: ITC, Lupin, Easy Trip, Unimech Aerospace, Mazagon Dock, Shriram Properties, Tanvi Foods, Hindalco in focus on 31 December
The pharma major has acquired Huminsulin in India from Eli Lilly to enhance its diabetes portfolio. Lupin has been ...